Could a simple breathing exercise ease pain and anxiety during nerve testing?
NCT ID NCT07702175
First seen Jul 14, 2026 · Last updated Jul 15, 2026 · Updated 1 time
Summary
This study investigates whether the 4-7-8 breathing technique can help reduce pain and anxiety in people with type 2 diabetes and diabetic neuropathy during an electromyography (EMG) procedure. EMG can be uncomfortable and stressful, and this trial compares the breathing technique to standard care. Participants are randomly assigned to either learn and apply the breathing method during the procedure or receive routine care, with pain and anxiety levels measured afterward.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- a controlled breathing exercise called the 4-7-8 breathing technique
- What this could lead to
- If effective, this simple breathing method could offer a low-cost, drug-free way to ease pain and anxiety during medical procedures like EMG.
- What could go wrong
- This is a small, early-stage study, and the results may not apply to everyone. The breathing technique may not significantly reduce pain or anxiety for all participants.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 100 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Jul 2026
An estimate. Start dates often move.
- Expected to finish
-
Apr 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 70 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Individuals aged 18-70 years who: * Have been diagnosed with Type 2 DM for at least one year, * Have diabetic peripheral neuropathy and are taking medications with a DN4 score \>3, * Are cooperative and can communicate in Turkish. • Do not have orthopedic or surgical contraindications that would prevent them from undergoing testing. Exclusion Criteria: * • Individuals with severe autonomic neuropathy findings (resting tachycardia, etc.), * Individuals with respiratory system diseases that prevent deep breathing, such as COPD and asthma, * Individuals with active infection or compromised skin integrity (dryness, cracks, open wounds, lesions, etc.) in the area where EMG will be performed, * Individuals with a mass (tumor, cystic formation, etc.) in the anatomical area where EMG will be performed, * Individuals with varicose veins (signs of venous insufficiency) in the anatomical area where EMG will be performed, * Individuals with edema in the area where EMG will be performed that may affect the quality of electrophysiological recordings, * Individuals with a dialysis catheter, central venous catheter, or implanted venous port, * Individuals who have used analgesics (painkillers) within 24 hours prior to the procedure, * Individuals who cannot follow breath commands due to hearing or visual impairment. • Individuals with any muscle disease, * Individuals receiving chemotherapy/radiotherapy treatment at any time, * Individuals who have undergone knee, hip, or lumbar surgery, * Pregnant women, * Individuals with any inflammatory rheumatic disease, * Patients with pacemakers or ICDs, * Individuals with chronic kidney failure
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Anxiety are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Osmaniye Training and Research Hospital
Osmaniye, Osmaniye, 80000, Turkey (Türkiye)
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Haptic feedback for improved interoceptive awareness and mental well-being: a comprehensive In-the-Wild study for wellness
- The effect of stress ball use during femoral arterial sheath removal after coronary angiography on pain, anxiety, patient satisfaction, and hemodynamic parameters
- The dynamic mechanism of mindfulness intervention for emotional distress (MIED) based on ecological moment measurement
- Effectiveness of shared decision Making（SDM）on patients with poor control type 2 diabetes
- Project QUIT+: adapting and testing a smoking cessation intervention for transgender and gender expansive individuals
- A placebo-controlled, proof-of-concept study to evaluate the safety and efficacy of lanifibranor alone and in combination with the sodium-glucose transport protein 2 (SGLT2) inhibitor EmpaGliflozin in patiEnts with non-alcoholic steatohepatitis (NASH) and type 2 diabetes mellitus (T2DM)